Fact CheckerSign in

NCT07479277Recruiting

Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC

A Multicenter, Randomized, Parallel-Group Trial Evaluating Progel Platinum Added to Mechanical Stapling Versus Mechanical Stapling Alone in Patients Undergoing VATS Upper or Lower Lobectomy for Non-Small Cell Lung Cancer

Source: ClinicalTrials.gov · Last updated 18 Mar 2026

Brief summary (registry, in English)

This multicenter randomized trial evaluates whether routine use of Progel Platinum surgical sealant on stapled fissure lines during VATS upper or lower lobectomy for NSCLC reduces pleural drainage duration compared with standard stapling alone. Secondary objectives include postoperative length of stay, incidence and duration of postoperative air leaks, residual pleural space, safety outcomes, and hospitalization costs.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
160 (estimated)
First submitted
9 Mar 2026
Start date
27 Feb 2026
Primary completion date
27 Feb 2027
Lead sponsor
Fondazione del Piemonte per l'Oncologia
Diseases
Lung cancer
NCT number
NCT07479277

What you commit to

  • Study type: Interventional
  • Planned participants: 160
  • From 27 Feb 2026 to the primary completion date, 27 Feb 2027
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Induction radiochemotherapy or chemo-immunotherapy
  • Sleeve resection or extended resection involving other lobes/chest wall/pericardium, etc.
  • Redo surgery

Other illness

  • Renal insufficiency

Lab values

  • Albumin intolerance/allergy

Other

  • Severe COPD: GOLD 3 or higher
  • Use of sealants/adhesives other than the study approach
  • Expected extensive pleural adhesions

Who the study is looking for

  • Age ≥18 years
  • Written informed consent
  • Planned VATS upper or lower lobectomy for NSCLC
  • Minimally invasive thoracoscopic approach
  • Middle lobectomy excluded

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ospedale centrale di Bolzano, Chirurgia Toracica e Vascolare
Coordinator of this site? Confirm its status
BolzanoItalyNot yet recruiting
Unità di Chirurgia Toracica Oncologica
Coordinator of this site? Confirm its status
CandioloItalyRecruiting
Azienda Ospedaliero-Universitaria Careggi
Coordinator of this site? Confirm its status
FlorenceItalyNot yet recruiting
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Coordinator of this site? Confirm its status
MilanItalyNot yet recruiting
Irccs Ismett
Coordinator of this site? Confirm its status
PalermoItalyNot yet recruiting
Azienda Ospedaliera Universitaria Pisana
Coordinator of this site? Confirm its status
PisaItalyNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.